Neogen Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹296 Cr +41.8% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
NC

Neogen Chemicals Ltd

Q4 FY26Chemicals & Petrochemicals

Neogen Chemicals Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹247Cr
+21.6% YoY
+12.1% QoQ
Net profit
₹11Cr
+372.6% YoY
+208.7% QoQ
Margin
17.81%
−0.1 pp YoY
+3.3 pp QoQ
Price₹2,230
Market cap₹5.5K Cr
P/E155.0

The short version

FY27 standalone (non-battery) revenue guidance: INR 875 to 950 crore; aiming to achieve up to INR 1,000 crore with organolithium/lithium sales growth. Revenue at Neogen is expected to grow significantly, targeting INR 3,700 to INR 4,200 crore consolidated revenue by FY29, including battery materials and existing business lines.

From Neogen Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • FY27 standalone (non-battery) revenue guidance: INR 875 to 950 crore; aiming to achieve up to INR 1,000 crore with organolithium/lithium sales growth.
  • FY28 Neogen full utilization target: INR 1,100+ crore revenue from existing business with optimization.
  • FY29 revenue projections:
  • Neogen business: INR 1,200 to 1,400 crore, conservatively INR 1,200-1,250 crore.
  • Battery chemicals (Neogen Ionics): INR 2,500 to 2,900 crore.
  • Consolidated revenue expected: INR 3,700 to 4,200 crore, potentially higher with additional salt capacity investments.
  • Electrolyte and salt capacity at Pakhajan site can scale up to 3x current 30 GWh to meet future demand.

2 more points from Neogen Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Neogen Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Additional investment expected in FY28 to increase salt capacity due to rising local and international electrolyte salt demand.
  • Potential further investments to expand organolithium, semiconductor-related, flavor & fragrance, and higher CSM needs.
  • Brownfield expansions planned at organolithium, Dahej, and Baroda sites targeting INR 4,000 to INR 5,000 crore revenue capacity.
  • Pakhajan facility capacity can be expanded up to 3x current 30 GWh electrolyte & salt capacity over five years depending on demand.
  • Revised project timeline for Pakhajan Phase 2 set for March 2027; includes electrolyte formulation and salted intermediate capacity.
  • Existing CAPEX funded through INR 160 crore equity from promoters plus $20 million from JV partner.

2 more points from Neogen Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Neogen Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Relevant insights include: - Strong demand and capacity utilization expected in battery electrolyte and salt business. - Existing capacity at Pakhajan supports around 30 GWh of electrolyte and salt production with potential to triple capacity. - Additional investments anticipated in electrolyte salt capacity due to rising local and international demand. - Capacity expansions planned at organolithium, Dahej, and Baroda sites with potential revenue reach of INR 4,000-5,000 crore via brownfield expansions. - Positive discussions ongoing for 6 gigafactories under construction. - The company highlights ability to meet 100% of key customer's electrolyte demand (2,000 MT current capacity plus 30,000 MT by H1).

2 more points from Neogen Chemicals Ltd's call on order book

Create a free account to keep reading this call

Neogen Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Neogen Chemicals Ltd Q4 FY26 results — key figures

Neogen Chemicals Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue247203+21.6%220+12.1%
Operating profit (EBITDA)4436+20.7%32+37.6%
Operating margin17.81%17.94%-0.1 pp14.5%+3.3 pp
Profit before tax164+330.7%6+175.2%
Net profit (PAT)112+372.6%4+208.7%
EPS (₹)4.320.91+374.7%1.40+208.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹296 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Neogen Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Neogen Chemicals Ltd Q4 FY26 results?

FY27 standalone (non-battery) revenue guidance: INR 875 to 950 crore; aiming to achieve up to INR 1,000 crore with organolithium/lithium sales growth. Revenue at Neogen is expected to grow significantly, targeting INR 3,700 to INR 4,200 crore consolidated revenue by FY29, including battery materials and existing business lines.

What is Neogen Chemicals Ltd share price analysis?

Neogen Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 155.0 with a market cap of ₹5,511 Cr. Investors should review the full earnings analysis for detailed insights.

Is Neogen Chemicals Ltd planning capital expenditure?

Additional investment expected in FY28 to increase salt capacity due to rising local and international electrolyte salt demand.

Keep Neogen Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.